Platinum and palladium nanoparticle-containing mixture, PAPLAL, does not induce palladium allergy

Shuichi Shibuya, Kenji Watanabe, Gaku Tsuji, Masamitsu Ichihashi, Takahiko Shimizu

Research output: Contribution to journalArticle

Abstract

Palladium (Pd) is a common metal found in jewellery and dental appliances, but it has been shown to be likely to cause metal allergy. We previously reported that platinum (nPt) and palladium (nPd) nanoparticle-containing mixture (PAPLAL) has both superoxide dismutase and catalase activities and that the topical application of PAPLAL improved skin atrophy induced by chronic oxidative damage in an ageing mouse model. However, the safety of PAPLAL for preventing Pd allergy remains unclear. In the present study, we investigated whether or not PAPLAL induces Pd allergy. We found that PAPLAL treatment caused no skin inflammation, while nPd administration caused only slight skin inflammation compared to the palladium chloride-induced severe reaction in an experimental metal allergy model. A gene expression analysis revealed that PAPLAL treatment significantly suppressed the expression of Inf-γ, Il-1β and Tnfα genes. Even in human clinical trials using patches containing metal nanoparticles, nPd and PAPLAL failed to induce significant skin inflammation. These results suggest that mixing with nPt in PAPLAL suppresses the inflammation response of nPd. PAPLAL can be expected to be applied to various skin treatments as a safe topical substance.

Original languageEnglish
JournalExperimental Dermatology
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Allergies
Palladium
Platinum
Nanoparticles
Hypersensitivity
Skin
Inflammation
Metals
Jewelry
Metal Nanoparticles
Metal nanoparticles
Gene expression
Catalase
Superoxide Dismutase
Atrophy
Tooth
Genes
Aging of materials
Clinical Trials
Safety

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Dermatology

Cite this

Platinum and palladium nanoparticle-containing mixture, PAPLAL, does not induce palladium allergy. / Shibuya, Shuichi; Watanabe, Kenji; Tsuji, Gaku; Ichihashi, Masamitsu; Shimizu, Takahiko.

In: Experimental Dermatology, 01.01.2019.

Research output: Contribution to journalArticle

Shibuya, Shuichi ; Watanabe, Kenji ; Tsuji, Gaku ; Ichihashi, Masamitsu ; Shimizu, Takahiko. / Platinum and palladium nanoparticle-containing mixture, PAPLAL, does not induce palladium allergy. In: Experimental Dermatology. 2019.
@article{3e75d9dc2e5c4fcb84eb03f767aa6cb5,
title = "Platinum and palladium nanoparticle-containing mixture, PAPLAL, does not induce palladium allergy",
abstract = "Palladium (Pd) is a common metal found in jewellery and dental appliances, but it has been shown to be likely to cause metal allergy. We previously reported that platinum (nPt) and palladium (nPd) nanoparticle-containing mixture (PAPLAL) has both superoxide dismutase and catalase activities and that the topical application of PAPLAL improved skin atrophy induced by chronic oxidative damage in an ageing mouse model. However, the safety of PAPLAL for preventing Pd allergy remains unclear. In the present study, we investigated whether or not PAPLAL induces Pd allergy. We found that PAPLAL treatment caused no skin inflammation, while nPd administration caused only slight skin inflammation compared to the palladium chloride-induced severe reaction in an experimental metal allergy model. A gene expression analysis revealed that PAPLAL treatment significantly suppressed the expression of Inf-γ, Il-1β and Tnfα genes. Even in human clinical trials using patches containing metal nanoparticles, nPd and PAPLAL failed to induce significant skin inflammation. These results suggest that mixing with nPt in PAPLAL suppresses the inflammation response of nPd. PAPLAL can be expected to be applied to various skin treatments as a safe topical substance.",
author = "Shuichi Shibuya and Kenji Watanabe and Gaku Tsuji and Masamitsu Ichihashi and Takahiko Shimizu",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/exd.13996",
language = "English",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Platinum and palladium nanoparticle-containing mixture, PAPLAL, does not induce palladium allergy

AU - Shibuya, Shuichi

AU - Watanabe, Kenji

AU - Tsuji, Gaku

AU - Ichihashi, Masamitsu

AU - Shimizu, Takahiko

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Palladium (Pd) is a common metal found in jewellery and dental appliances, but it has been shown to be likely to cause metal allergy. We previously reported that platinum (nPt) and palladium (nPd) nanoparticle-containing mixture (PAPLAL) has both superoxide dismutase and catalase activities and that the topical application of PAPLAL improved skin atrophy induced by chronic oxidative damage in an ageing mouse model. However, the safety of PAPLAL for preventing Pd allergy remains unclear. In the present study, we investigated whether or not PAPLAL induces Pd allergy. We found that PAPLAL treatment caused no skin inflammation, while nPd administration caused only slight skin inflammation compared to the palladium chloride-induced severe reaction in an experimental metal allergy model. A gene expression analysis revealed that PAPLAL treatment significantly suppressed the expression of Inf-γ, Il-1β and Tnfα genes. Even in human clinical trials using patches containing metal nanoparticles, nPd and PAPLAL failed to induce significant skin inflammation. These results suggest that mixing with nPt in PAPLAL suppresses the inflammation response of nPd. PAPLAL can be expected to be applied to various skin treatments as a safe topical substance.

AB - Palladium (Pd) is a common metal found in jewellery and dental appliances, but it has been shown to be likely to cause metal allergy. We previously reported that platinum (nPt) and palladium (nPd) nanoparticle-containing mixture (PAPLAL) has both superoxide dismutase and catalase activities and that the topical application of PAPLAL improved skin atrophy induced by chronic oxidative damage in an ageing mouse model. However, the safety of PAPLAL for preventing Pd allergy remains unclear. In the present study, we investigated whether or not PAPLAL induces Pd allergy. We found that PAPLAL treatment caused no skin inflammation, while nPd administration caused only slight skin inflammation compared to the palladium chloride-induced severe reaction in an experimental metal allergy model. A gene expression analysis revealed that PAPLAL treatment significantly suppressed the expression of Inf-γ, Il-1β and Tnfα genes. Even in human clinical trials using patches containing metal nanoparticles, nPd and PAPLAL failed to induce significant skin inflammation. These results suggest that mixing with nPt in PAPLAL suppresses the inflammation response of nPd. PAPLAL can be expected to be applied to various skin treatments as a safe topical substance.

UR - http://www.scopus.com/inward/record.url?scp=85070072009&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070072009&partnerID=8YFLogxK

U2 - 10.1111/exd.13996

DO - 10.1111/exd.13996

M3 - Article

C2 - 31260134

AN - SCOPUS:85070072009

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

ER -